Document:

Document

RESTRICTED STOCK GRANT NOTICE
UNDER THE
PRA HEALTH SCIENCES, INC.
2020 STOCK INCENTIVE PLAN
(Time-Based Vesting Award for Directors)

PRA Health Sciences, Inc. (the “Company”), pursuant to the PRA Health Sciences, Inc. 2020 Stock Incentive Plan (the “Plan”), hereby grants to the Participant set forth below the number of shares of Restricted Stock set forth below.  The shares of Restricted Stock are subject to all of the terms and conditions as set forth herein, in the Restricted Stock Agreement (attached hereto or previously provided to the Participant in connection with a prior grant), and in the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein shall have the meaning set forth in the Plan.
Participant:    [    ]
Date of Grant:    [    ] 
Number of Shares of
Restricted Stock:    [    ]

Vesting Schedule:   Provided the Participant has not undergone a Termination prior to the time of each applicable vesting date (or event), [    ].
Notwithstanding the foregoing, in the event that the Participant undergoes a Termination on the date of a regularly scheduled annual meeting of the stockholders of the Company that is prior to the first anniversary of the Date of Grant as a result of the Participant not being reelected for another term as a Non-Employee Director, the shares of Restricted Stock otherwise scheduled to vest on such first anniversary of the Date of Grant shall immediately vest, and the restrictions thereon shall lapse upon such Termination.
            Notwithstanding the foregoing, in the event that (i) the Participant undergoes a Termination as a result of the Participant’s death or Disability, or (ii) on or following a Change in Control but prior to the first anniversary of such Change in Control, the Participant ceases to be a member of the Board as a result of the Change in Control, the shares of Restricted Stock shall become fully vested, and the restrictions thereon shall lapse, on the date of such Termination.
1
2020 SIP Director RSA Form [5/2020]

Additional Terms:   The Participant may make an election under Section 83(b) of the Code in connection with the grant of Restricted Stock hereunder, provided the Participant notifies the Company within ten (10) days of such election and provides the Company with a copy of the same.

* * *

2
2020 SIP Director RSA Form [5/2020]

BY ACCEPTING THIS AWARD, THE PARTICIPANT ACKNOWLEDGES RECEIPT OF THIS RESTRICTED STOCK GRANT NOTICE, THE RESTRICTED STOCK AGREEMENT AND THE PLAN, AND, AS AN EXPRESS CONDITION TO THE GRANT OF SHARES OF RESTRICTED STOCK HEREUNDER, AGREES TO BE BOUND BY THE TERMS OF THIS RESTRICTED STOCK GRANT NOTICE, THE RESTRICTED STOCK AGREEMENT AND THE PLAN.
 
PRA Health Sciences, Inc.  Participant

________________________________  ________________________________

3
2020 SIP Director RSA Form [5/2020]

         

RESTRICTED STOCK AGREEMENT
UNDER THE
PRA HEALTH SCIENCES, INC.
2020 STOCK INCENTIVE PLAN
Pursuant to the Restricted Stock Grant Notice (the “Grant Notice”) delivered to the Participant (as defined in the Grant Notice), and subject to the terms of this Restricted Stock Agreement (this “Restricted Stock Agreement”) and the PRA Health Sciences, Inc. 2020 Stock Incentive Plan (the “Plan”), PRA Health Sciences, Inc. (the “Company”) and the Participant agree as follows.  Capitalized terms not otherwise defined herein shall have the same meaning as set forth in the Plan. 
1.Grant of Shares of Restricted Stock.  Subject to the terms and conditions set forth herein and in the Plan, the Company hereby grants to the Participant the number of shares of Restricted Stock provided in the Grant Notice.  The Company may make one or more additional grants of shares of Restricted Stock to the Participant under this Restricted Stock Agreement by providing the Participant with a new Grant Notice, which may also include any terms and conditions differing from this Restricted Stock Agreement to the extent provided therein.  The Company reserves all rights with respect to the granting of additional shares of Restricted Stock hereunder and makes no implied promise to grant additional shares of Restricted Stock. 
2.Vesting.  Subject to the conditions contained herein and in the Plan, the shares of Restricted Stock shall vest and the restrictions on such shares of Restricted Stock shall lapse as provided in the Grant Notice.  With respect to any share of Restricted Stock, the period of time that such share of Restricted Stock remains subject to vesting shall be its Restricted Period.
3.Issuance of Shares.  Upon the expiration of the Restricted Period with respect to any shares of Restricted Stock, the restrictions set forth herein and in the Grant Notice as applicable to Restricted Stock shall be of no further force or effect with respect to such Shares. If an escrow arrangement is used, upon such expiration, the Company shall issue to the Participant, or the Participant's beneficiary, without charge, the shares of Restricted Stock which have not then been forfeited and with respect to which the Restricted Period has expired (rounded down to the nearest full share).
4.Treatment upon Termination.  Except as otherwise provided in the Grant Notice, in the event of the Participant’s Termination for any reason prior to the date that all of the shares of the Participant’s Restricted Stock have vested, (i) all vesting with respect to the Participant’s Restricted Stock shall cease, and (ii) all unvested shares of Restricted Stock shall be forfeited to the Company by the Participant for no consideration as of the date of such Termination.
5.Non-Transferability.  The shares of Restricted Stock are not transferable by the Participant other than (i) by will or the laws of descent and distribution or (ii) to Permitted Transferees, as specifically approved in writing by the Committee following written notice to the 
4
2020 SIP Director RSA Form [5/2020]

         

Committee, in accordance with Section 14(b) of the Plan.  Except as otherwise provided herein, no assignment or transfer of the shares of Restricted Stock, or of the rights represented thereby, whether voluntary or involuntary, by operation of law or otherwise, shall vest in the assignee or transferee any interest or right herein whatsoever, but immediately upon such assignment or transfer the shares of Restricted Stock shall terminate and become of no further effect. 
Whenever the word “Participant” is used in any provision of this Restricted Stock Agreement under circumstances where the provision should logically be construed to apply to the executors, the administrators, or the person or persons to whom the shares of Restricted Stock may be transferred, the word “Participant” shall be deemed to include such person or persons. 
6.Rights as Stockholder.  Upon the grant of Restricted Stock, the Committee shall cause the share(s) to be held in book-entry form subject to the Company’s directions and, if the Committee determines that the Restricted Stock shall be held by the Company or in escrow rather than issued to the Participant pending the expiration of the Restricted Period, the Committee may require the Participant to additionally execute and deliver to the Company (i) an escrow agreement satisfactory to the Committee, if applicable; and (ii) the appropriate stock power (endorsed in blank) with respect to the Restricted Stock covered by such agreement. Subject to applicable restrictions herein and in Section 14(c) of the Plan, a Participant generally shall have the rights and privileges of a stockholder as to shares of Restricted Stock, including, without limitation, the right to vote such Restricted Stock. To the extent shares of Restricted Stock are forfeited, all rights of the Participant to such shares and as a stockholder with respect thereto shall terminate without further obligation on the part of the Company. 
7.Taxes.  The Participant acknowledges that the Participant will consult with his or her personal tax advisor regarding any or all income tax, social insurance, payroll tax, fringe benefit, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable to the Participant (the “Tax-Related Items”).  The Participant is relying solely on such advisor and is not relying in any part on any statement or representation of the Company or any of its agents.  The Company will not be responsible for withholding any Tax-Related Items, unless required by Applicable Laws.  The Company may take such action as it deems appropriate to ensure that all Tax-Related Items, which are the Participant’s sole and absolute responsibility, are withheld or collected from the Participant, if and to the extent required by Applicable Laws.  In this regard, the Participant authorizes the Company or its agents, at their discretion to satisfy any applicable withholding obligation for Tax-Related Items by one or a combination of the following: 
(a)selling on the market (on the Participant’s behalf pursuant to this authorization without further consent) a number of the shares of Restricted Stock that have vested and that the Company determines to be appropriate to generate cash proceeds sufficient to satisfy the withholding obligation for Tax-Related Items;

(b)withholding such amount from any cash compensation or other cash amounts owing to the Participant; 

5
2020 SIP Director RSA Form [5/2020]

         

(c)requiring the Participant to tender to the Company shares of Restricted Stock that have vested with a then current Fair Market Value sufficient to satisfy the applicable withholding obligation for Tax-Related Items; or

(d)any other method of withholding determined by the Company and permitted by Applicable Laws;

provided, however, that the form of withholding specified in subsection (c) above must be authorized by the Committee (as constituted to satisfy Rule 16b-3 under the Exchange Act) if the Participant is an officer of the Company within the meaning of Section 16 of the Exchange Act.
The Company may withhold or account for Tax-Related Items by considering statutory withholding rates or other withholding rates, including maximum rates applicable in the Participant’s jurisdiction(s), in which case the Participant may receive a refund of any over-withheld amount in cash and will have no entitlement to the equivalent amount in Shares. If the obligation for Tax-Related Items is satisfied by the Participant tendering in Shares to the Company, for tax purposes, the Participant shall be deemed to have been issued the full number of Shares subject to the vested Restricted Stock, notwithstanding that a number of the Shares are tendered solely for the purpose of paying the Tax-Related Items.
The Participant agrees to pay to the Company any amount of Tax-Related Items that the Company may be required to withhold or account for as a result of the Participant’s participation in the Plan that cannot be satisfied by the means previously described. The Company may refuse to issue or deliver the Shares, or the proceeds of the sale of Shares, if the Participant fails to comply with his or her obligations in connection with the Tax-Related Items.
8.Data Privacy.  The Participant hereby explicitly and unambiguously consents to the collection, use, processing and transfer, in electronic or other form, of the Participant’s personal data as described in this document by and among, as applicable, the Company and its Affiliates for the exclusive purpose of implementing, administering and managing his or her participation in the Plan.
The Participant understands that the Company and the Service Provider hold certain personal information about the Participant, specifically: the Participant’s name, home address and telephone number, email address, date of birth, sex, age, nationality, social insurance number, resident registration number or other identification number, job title, tax-related information, plan or benefit enrollment forms and elections, award or benefit statements, any shares in the Company, details of all awards or any other entitlements to shares awarded, canceled, purchased, vested, unvested or outstanding for purpose of managing and administering the Plan (“Data”).

The Participant understands that Data may be transferred to E*TRADE (or any successor Plan broker) and any third parties assisting in the implementation, administration and management of the Plan including, but not limited to, the Affiliates of the Company. These third-party recipients may be located in the Participant’s country of residence (and country of service, 
6
2020 SIP Director RSA Form [5/2020]

         

if different) or elsewhere, and the recipient’s country may have different data privacy laws and protections than the Participant’s country. 

The Participant authorizes the recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant’s participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom the Participant may elect to deposit any shares acquired. The Participant understands that Data only will be held as long as is necessary to implement, administer and manage the Participant’s participation in the Plan. 

If the Participant does not consent, or if the Participant later seeks to revoke his or her consent, the Participant’s service status and career will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant the Participant shares of Restricted Stock or administer or maintain such shares of Restricted Stock. Therefore, the Participant understands that refusing or withdrawing his or her consent may affect the Participant’s ability to participate in the Plan. For more information on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact his or her local human resources department.

9.Notice.  Every notice or other communication relating to this Restricted Stock Agreement between the Company and the Participant shall be in writing, and shall be mailed to or delivered to the party for whom it is intended at such address as may from time to time be designated by such party in a notice mailed or delivered to the other party as herein provided; provided that, unless and until some other address be so designated, all notices or communications by the Participant to the Company shall be mailed or delivered to the Company at its principal executive office, to the attention of the Company General Counsel, and all notices or communications by the Company to the Participant may be given to the Participant personally (through email or otherwise) or may be mailed to the Participant at the Participant’s last known address, as reflected in the Company’s records.  Notwithstanding the above, all notices and communications between the Participant and any third-party plan administrator shall be mailed, delivered, transmitted or sent in accordance with the procedures established by such third-party plan administrator and communicated to the Participant from time to time. 
10.Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s participation in the Plan, on the Restricted Stock, and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant (or, in the event of the Participant’s death, his or her legal representatives, legates or distributees) to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. 
11.Binding Effect.  This Restricted Stock Agreement shall be binding upon the heirs, executors, administrators and successors of the parties hereto. 
12.Compliance with Law.  Notwithstanding any other provision of the Plan or this Restricted Stock Agreement, unless there is an available exemption from any registration, 
7
2020 SIP Director RSA Form [5/2020]

         

qualification or other legal requirement applicable to the Shares, the Company shall not be required to deliver any Shares upon vesting of the Restricted Stock prior to the completion of any registration or qualification of the Common Stock under applicable federal, state or local securities or exchange control law or under rulings or regulations of the SEC or of any other governmental regulatory body, or prior to obtaining any approval or other clearance from any governmental agency, which registration, qualification or approval the Company shall, in its absolute discretion, deem necessary or advisable. The Participant understands that the Company is under no obligation to register or qualify the Common Stock with the SEC or any state securities commission or to seek approval or clearance from any governmental authority for the issuance or sale of the Common Stock. Further, the Participant agrees that the Company shall have unilateral authority to amend the Plan and this Restricted Stock Agreement without the Participant’s consent to the extent necessary to comply with Applicable Laws governing the issuance of Common Stock.
13.No Advice Regarding Grant.  The Company is not providing any tax, legal or financial advice, nor is the Company making any recommendations regarding the Participant’s participation in the Plan, or the Participant’s acquisition or sale of Shares.  The Participant should consult with his or her own personal tax, legal and financial advisors regarding his or her participation in the Plan before taking any action related to the Plan.
14.Electronic Delivery and Acceptance.  The Company, in its sole discretion, may decide to deliver any documents related to current or future participation in the Plan by electronic means.  The Participant hereby consents to receive such documents by electronic delivery and agrees to accept this Restricted Stock Agreement or otherwise participate in the Plan in the future through an on-line or electronic system established and maintained by the Company or a third party designated by the Company.
15.Severability.  The provisions of this Restricted Stock Agreement are severable and if any one or more provisions are determined to be illegal or otherwise unenforceable, in whole or in part, the remaining provisions shall nevertheless be binding and enforceable.
16.Amendments and Modifications; Waiver.  Except as otherwise set forth in Section 13 of the Plan, any waiver, alteration, amendment or modification of any of the terms of this Restricted Stock Agreement shall be valid only if made in writing and signed by the parties hereto.  
No waiver by either of the parties hereto of their rights hereunder shall be deemed to constitute a waiver with respect to any other provision of this Restricted Stock Agreement or any subsequent occurrences or transactions hereunder unless such waiver specifically states that it is to be construed as applicable to other provisions of this Restricted Stock Agreement or a continuing waiver. 
17.Governing Law.  This Restricted Stock Agreement shall be construed and interpreted in accordance with the laws of the State of Delaware, without regard to the principles of conflicts of law thereof.  NOTWITHSTANDING ANYTHING CONTAINED IN THIS 
8
2020 SIP Director RSA Form [5/2020]

         

RESTRICTED STOCK AGREEMENT, THE GRANT NOTICE OR THE PLAN TO THE CONTRARY, BY ACCEPTING THIS AWARD, THE PARTICIPANT HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHTS TO A JURY TRIAL AND SUBMITS TO THE EXCLUSIVE JURISDICTION OF AND VENUE IN THE COURTS OF DELAWARE, IF ANY SUIT OR CLAIM IS INSTITUTED BY THE PARTICIPANT OR THE COMPANY RELATING TO THIS RESTRICTED STOCK AGREEMENT. 
18.Plan.  The terms and provisions of the Plan are incorporated herein by reference.  In the event of a conflict or inconsistency between the terms and provisions of the Plan and the provisions of this Restricted Stock Agreement, the Plan shall govern and control. 

9
2020 SIP Director RSA Form [5/2020]Exhibit 10.10

 

THE SECURITIES DESCRIBED HEREIN HAVE NOT BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS
ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.

 

THE PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF
RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

 

SUBSCRIPTION AGREEMENT

 

This Subscription Agreement (this “Agreement”)
is entered into as of August 14, 2020 between Growth Capital Acquisition Corp., a Delaware corporation (the “Company”)
and Nautilus Carriers LLC, a Delaware limited liability company (the “Purchaser”).

 

RECITALS

 

WHEREAS, the Company was incorporated for
the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar
business combination with one or more businesses (a “Business Combination”);

 

WHEREAS, the Company has confidentially
submitted to the U.S. Securities and Exchange Commission (the “SEC”) a draft registration statement on Form
S-1 (the “Registration Statement”) for its initial public offering (“IPO”) of units (the
 “Public Units”), at a price of $10.00 per Public Unit, each Public Unit comprised of one share of the Company’s
Class A common stock, par value $0.0001 per share (“Class A Common Stock”, and the shares of Class A Common
Stock included in the Public Units, the “Public Shares”), and one-half of one redeemable warrant, where each
whole warrant is initially exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share,
subject to adjustment (the “Warrants”, and the Warrants included in the Public Units, the “Public
Warrants”);

 

WHEREAS, proceeds from the IPO and the
sale of the Private Placement Units (as defined below) in an aggregate amount equal to the aggregate gross proceeds from the IPO
will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust Account”),
as described in the Registration Statement;

 

WHEREAS, following the closing of the IPO
(the “IPO Closing”), the Company will seek to identify and consummate a Business Combination;

 

WHEREAS, in connection with the IPO, the
Purchaser will purchase, in a private placement that will close simultaneously with the IPO Closing, 155,167 units (“Base
Private Placement Units”), each Private Placement Unit consisting of one share of Class A Common Stock and one-half
of one warrant (“Private Placement Warrants”) (or 171,667 Private Placement Units if the underwriters’
over-allotment option is exercised in full; the additional Private Placement Units to be purchased, the “Over-allotment
Private Placement Units” and, together with the Base Private Placement Units, the “Private Placement Units”)
at a price of $10.00 per Private Placement Unit for an aggregate purchase price of $1,551,670 (or up to $1,716,670 if the underwriters’
over-allotment option is exercised in full). Such Private Placement Units shall be identical to the Public Units, subject to certain
exceptions described in the Registration Statement;

 

WHEREAS, the parties wish to enter into
this Agreement, pursuant to which the Purchaser shall subscribe for and purchase (i) 1,379,167 shares of Class B common stock,
par value $0.0001 per share, of the Company (“Class B Shares” and collectively with the shares of Class A Common
Stock to be issued in the IPO, the “Common Stock”), of which up to 187,500 Class B Shares shall be subject
to forfeiture, for an aggregate purchase price of $2,043 (“Class B Purchase Price”) as provided herein or as
otherwise agreed, and (ii) the Private Placement Units (together with the Class B Shares to be purchased by the Purchaser, the
 “Subscribed Securities”); and

 

     

     

    

 

WHEREAS, the Company and the Purchaser intend for the purchase
of Class B Shares and Private Placement Units as set forth herein to be made pursuant to Rule 506(c) of Regulation D promulgated
under the Securities Act.

 

NOW, THEREFORE, in consideration of the premises, representations,
warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt, sufficiency
and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

 

1. Sale and Purchase.

 

(a) Securities.

 

(i) Subject to the terms and conditions
hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company, and the Company agrees to issue
and sell to the Purchaser, the Subscribed Securities, and any securities of the Company that may be distributed to the Purchaser
on account of the Subscribed Securities (collectively, the “Securities”), will be subject to restrictions on
transfer as set forth in this Agreement.

 

(ii) On the date hereof, against payment in full of the Class
B Purchase Price, the Company shall issue to the Purchaser 1,379,167 Class B Shares of which up to 187,500 are subject to forfeiture
in consideration for the Purchaser’s payment of the Class B Purchase Price, by wire transfer of immediately available funds
or other means approved by the Company.

 

(iii) Subject to the terms and
conditions hereof, the Purchaser hereby irrevocably subscribes for and agrees to purchase from the Company, and the Company agrees
to issue and sell to the Purchaser, Private Placement Units and, subject to the provisions set forth below, the Over-allotment
Private Placement Units, at a purchase price of $10.00 per Private Placement Unit (the amount to be paid by the Purchaser for
the Private Placement Units, the “PPU Purchase Price”),

 

(iv) The Company shall notify the
Purchaser in writing of the anticipated date of the effectiveness of the Registration Statement (the “Effective Date”)
at least three (3) Business Days (as defined below) prior to the Effective Date, and the Purchaser shall remit the PPU Purchase
Price to the Company’s transfer agent (to be held in escrow pending the IPO Closing), by wire transfer of immediately available
funds or other means approved by the Company, on the date that is not less than one (1) Business Day prior to the Effective Date,
or such other date as the Company and the Purchaser may agree upon in writing. As used herein, “Business Day”
means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on which banking institutions are
generally authorized or required by law or regulation to close in the City of New York, New York, provided, however, for clarification,
banking institutions shall not be deemed to be authorized or required by law to remain closed due to “stay at home,”
 “shelter-in-place,” “non-essential employee” or any other similar orders or restrictions or the closure
of any physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems
(including for wire transfers) of banking institutions in the City of New York, New York generally are open for use by customers
on such day. If the IPO Closing has not occurred by the date that is ten (10) Business Days after Effective Date (or if the Effective
Date has not occurred within seven (7) Business Days after the Purchaser shall have transferred the PPU Purchase Price to the
Company’s transfer agent, then, unless the Purchaser otherwise agrees in writing, the Company will promptly cause its transfer
agent to return the PPU Purchase Price to the Purchaser.

 

(v) In the event that the underwriters’
over-allotment option in connection with the IPO (the “Over-allotment Option”) is exercised, the Purchaser
agrees to purchase additional Over-allotment Private Placement Units at a price of $10.00 per Private Placement Unit, at the rate
of 733 Private Placement Units for each 100,000 Public Units (or fraction thereof) the underwriters elect to purchase pursuant
to the Over-allotment option. The Company shall notify the Purchaser in writing of the anticipated date of each closing of the
exercise of the Over-allotment Option, if any (each, an “Over-allotment Closing”) at least three (3) Business
Days prior to such Over-allotment Closing, and the Purchaser shall pay the purchase price for the Private Placement Units to be
purchased in connection with such Over-allotment Closing by wire transfer of immediately available funds or other means approved
by the Company on that date that is one (1) Business Day prior to such Over-allotment Closing (to be held in escrow pending such
Over-allotment Closing), or such other date as the Company may agree upon in writing. If the Overallotment Closing has not occurred
by the date that is seven (7) Business Days after the date on which the Purchaser remitted the purchase price for the Private
Placement Units to be purchased in connection with such Over-allotment Closing, then, unless the Company otherwise agrees in writing,
the Company will promptly cause its transfer agent to return such amounts to the Purchaser.

 

     

     

    

 

(vi) On the date of the IPO Closing, the Company shall issue
to the Purchaser 155,167 Base Private Placement Units. On the date of each Over-allotment Closing, if any, against payment of the
purchase price therefor, the Company shall issue to Purchaser the number of Over-Allotment Private Placement Units set forth above.

 

(vii) The Purchaser acknowledges that the Securities will be
subject to restrictions on transfer as set forth in this Agreement or in the agreements referred to herein.

 

(b) Delivery of Securities.

 

(i) The Company shall register the Purchaser as the owner of
the Subscribed Securities with the Company’s transfer agent by book entry on or prior to the date of the IPO Closing (provided
that prior to the Company’s appointment of a transfer agent it shall register the Purchaser as the owner of such securities
in the Company’s stock ledger upon issuance thereof).

 

(ii) Each register and book entry for the Securities shall contain
a notation, and each certificate (if any) evidencing the Securities shall be stamped or otherwise imprinted with a legend, in substantially
the following form:

 

“THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND MAY
NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.

 

THE SALE, PLEDGE, HYPOTHECATION, OR TRANSFER OF THE SECURITIES
REPRESENTED HEREBY ARE SUBJECT TO THE TERMS AND CONDITIONS OF A CERTAIN SUBSCRIPTION AGREEMENT BY AND AMONG THE HOLDER AND THE
OTHER PARTIES THERETO. COPIES OF SUCH AGREEMENT MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE COMPANY.”

 

(c) Execution of Letter Agreement.
On the Effective Date, the Purchaser shall enter into a Letter Agreement (the “Insider Letter Agreement”) with
the Company and certain other parties thereto, in such form as may be required pursuant to the underwriting agreement in connection
with the IPO. The Insider Letter Agreement shall provide, among other matters, if the Company seeks stockholder approval of a
proposed Business Combination, the Purchaser shall vote any shares of Class B Common Stock or shares under the Private Placement
Units owned by it, in favor of any proposed Business Combination and not redeem any shares of Common Stock owned by it in connection
with such stockholder approval.

 

(d) Registration Rights. On the Effective
Date, the Company shall enter into a Registration Rights Agreement (the “Registration Rights Agreement”) with
the Purchaser and certain other parties thereto, in substantially the form provided to the Purchaser prior to the date hereof.
The Registration Rights Agreement shall provide the Purchaser with registration rights with respect to (i) the Securities that
are no less favorable to the Purchaser than the registration rights any other holder of Securities set forth therein and (ii)
any Public Units (including the shares of Class A Common Stock and warrants included in the Public Units) acquired by the Purchaser
in the IPO, if the Purchaser is an affiliate of the Company following the IPO.

 

     

     

    

 

2. Representations and Warranties of the Purchaser. The
Purchaser represents and warrants to the Company as follows, as of the date hereof:

 

(a) Organization and Power. The Purchaser
is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its formation and has all requisite
power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b) Authorization. The Purchaser has
full power and authority to enter into this Agreement. This Agreement, when executed and delivered by the Purchaser, will constitute
the valid and legally binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except
(i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general
application affecting enforcement of creditors’ rights generally or (ii) as limited by laws relating to the availability
of specific performance, injunctive relief or other equitable remedies.

 

(c) Governmental Consents and Filings.
No consent, approval, order or authorization of, or registration, qualification, designation, declaration or filing with, any
federal, state or local governmental authority is required on the part of the Purchaser in connection with the consummation of
the transactions contemplated by this Agreement, except for filings pursuant to applicable securities laws, rules or regulations.

 

(d) Compliance with Other Instruments.
The execution, delivery and performance by the Purchaser of this Agreement and the consummation by the Purchaser of the transactions
contemplated by this Agreement will not result in any violation or default (i) under any provisions of its organizational documents,
(ii) under any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under any note,
indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order
to which it is a party or by which it is bound or (v) under any provision of federal or state statute, rule or regulation applicable
to the Purchaser, in each case (other than clause (i)), which would have a material adverse effect on the Purchaser’s ability
to consummate the transactions contemplated by this Agreement.

 

(e) Purchase Entirely for Own Account.
This Agreement is made with the Purchaser in reliance upon the Purchaser’s representation to the Company, which by the Purchaser’s
execution of this Agreement, the Purchaser hereby confirms, that the Securities to be acquired by the Purchaser will be acquired
for investment for the Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution
of any part thereof in violation of any state or federal securities laws, and that the Purchaser has no present intention of selling,
granting any participation in, or otherwise distributing the same in violation of law. By executing this Agreement, the Purchaser
further represents that the Purchaser does not presently have any contract, undertaking, agreement or arrangement with any Person
(other than the Company) to sell, transfer or grant participations to such Person or to any third Person, with respect to any
of the Securities. For purposes of this Agreement, “Person” means an individual, a limited liability company,
a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or any government or
any department or agency thereof.

 

(f) Disclosure of Information. The
Purchaser has had an opportunity to discuss the Company’s business, management, financial affairs and the terms and conditions
of the offering of the Securities, as well as the terms of the Company’s proposed IPO, with the Company’s management.

 

(g) Restricted Securities. The Purchaser
understands that the offer and sale of the Securities to the Purchaser has not been and will not be registered under the Securities
Act, by reason of a specific exemption from the registration provisions of the Securities Act which depends upon, among other
things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s representations as expressed herein.
The Purchaser understands that the Securities are “restricted securities” under applicable U.S. federal and state
securities laws and that, pursuant to these laws, the Purchaser must hold the Securities indefinitely unless they are registered
with the SEC and qualified by state authorities, or an exemption from such registration and qualification requirements is available.
The Purchaser acknowledges that the Company has no obligation to register or qualify the Securities except pursuant to the Registration
Rights Agreement. The Purchaser further acknowledges that if an exemption from registration or qualification is available, it
may be conditioned on various requirements including, but not limited to, the time and manner of sale, the holding period for
the Securities, and on requirements relating to the Company which are outside of the Purchaser’s control, and which the
Company is under no obligation and may not be able to satisfy. The Purchaser acknowledges that the Company has confidentially
submitted the Registration Statement for its proposed IPO. The Purchaser understands that the offering of Securities and transactions
contemplated hereunder are not and are not intended to be part of the IPO, and that the Purchaser will not be able to rely on
the protection of Section 11 of the Securities Act with respect to its purchase of Securities hereunder.

 

     

     

    

 

(h) No Public Market. The Purchaser
understands that no public market now exists for the Securities, and that the Company has not made any assurances that a public
market will ever exist for the Securities.

 

(i) High Degree of Risk. The Purchaser
understands that the purchase of the Subscribed Securities involves a high degree of risk which could cause the Purchaser to lose
all or part of its investment.

 

(j) Accredited Investor. The Purchaser
is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Securities Act.

 

(k) No General Solicitation. Neither
the Purchaser, nor any of its officers, directors, employees, agents, stockholders or partners has either directly or indirectly,
including, through a broker or finder (i) to its

knowledge, engaged in any general solicitation, or (ii) published
any advertisement in connection with the offer and sale of the Securities.

 

(l) Adequacy of Financing. The Purchaser
will, when such funds are due hereunder, have sufficient funds to satisfy its obligations under this Agreement.

 

(m) No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 3 and in any certificate
or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on behalf of the Purchaser nor any of the
Purchaser’s affiliates (the “Purchaser Parties”) has made, makes or shall be deemed to make any other
express or implied representation or warranty with respect to the Purchaser and this offering, and the Purchaser Parties disclaim
any such representation or warranty. Except for the specific representations and warranties expressly made by the Company in Section
4 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Purchaser Parties specifically disclaim
that they are relying upon any other representations or warranties that may have been made by the Company, any person on behalf
of the Company or any of the Company’s affiliates (collectively, the “Company Parties”) with respect
to the transactions contemplated hereby.

 

3. Representations, Warranties and Covenants of the Company.
The Company represents, warrants and covenants to the Purchaser as follows:

 

(a) Organization and Corporate Power.
The Company is incorporated and validly existing and in good standing as a corporation under the laws of Delaware and has all
requisite corporate power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b) Capitalization. The authorized
share capital of the Company consists, as of the date hereof, of:

 

(i) 100,000,000 shares of Class A Common Stock, none of which
are issued and outstanding;

 

(ii) 10,000,000 Class B Shares, 4,312,500 of which are issued
and outstanding. All of the outstanding Class B Shares have been duly authorized, are fully paid and nonassessable and were issued
in compliance with all applicable federal and state securities laws; and

 

(iii) 1,000,000 shares of preferred stock, none of which are
issued and outstanding.

 

(c) Authorization. All corporate action
required to be taken by the Company’s Board of Directors and stockholders in order to authorize the Company to enter into
this Agreement, and to issue the Subscribed Securities and to carry out the other transactions contemplated hereby, has been taken
on or prior to the date hereof. All action on the part of the stockholders, directors and officers of the Company necessary for
the execution and delivery of this Agreement, the performance of all obligations of the Company under this Agreement, and the
issuance and delivery of the Subscribed Securities has been taken on or prior to the date hereof. This Agreement, when executed
and delivered by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the
Company in accordance with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent
conveyance, or other laws of general application relating to or affecting the enforcement of creditors’ rights generally
or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

     

     

    

 

(d) Valid Issuance of Securities.

 

(i) The Subscribed Securities,
when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be validly
issued and fully paid, as applicable, and free of all preemptive or similar rights, taxes, liens, encumbrances and charges with
respect to the issue thereof and restrictions on transfer other than restrictions on transfer specified under this Agreement,
applicable state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy
of the representations of the Purchaser in this Agreement and subject to the filings described in Section 4(e) below, the
Subscribed Securities will be issued in compliance with all applicable federal and state securities laws, rules and regulations.

 

(ii) No “bad actor”
disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”)
is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except for a
Disqualification Event as to which Rule 506(d)(2)(ii–iv) or (d)(3), is applicable. “Company Covered Person”
means, with respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any
Person listed in the first paragraph of Rule 506(d)(1).

 

(e) IPO.

 

(i) The Company has provided to the Purchaser, and will at all
times prior to the consummation of the IPO promptly provide to the Purchaser, copies of all correspondence sent by the Company
to, or received by the Company from, the SEC.

 

(ii) The offers and sales of securities in the IPO will be made
pursuant to an effective Registration Statement and otherwise in compliance with the Securities Act and the rules and regulations
promulgated thereunder and applicable state securities laws, rules and regulations.

 

(f) Governmental Consents and Filings.
Assuming the accuracy of the representations made by the Purchaser in this Agreement, no consent, approval, order or authorization
of, or registration, qualification, designation, declaration or filing with, any federal, state or local governmental authority
is required on the part of the Company in connection with the consummation of the transactions contemplated by this Agreement,
except for filings pursuant to Regulation D of the Securities Act and applicable state securities laws, if any.

 

(g) Compliance with Other Instruments.
The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated by this Agreement
will not result in any violation or default (i) under any provisions of the certificate of incorporation, bylaws or other governing
documents of the Company, (ii) under any instrument, judgment, order, writ or decree to which the Company is a party or by which
it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound, (iv) under any
lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) under any provision
of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which would have
a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement.

 

(h) Operations. As of the date hereof,
the Company has not conducted, and prior to the IPO Closing the Company will not conduct, any operations other than organizational
activities and activities in connection with offerings of the Securities.

 

     

     

    

 

(i) Foreign Corrupt Practices. Neither
the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company has, in the course of
its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift, entertainment
or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any foreign or
domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the U.S.
Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.

 

(j) Compliance with Anti-Money Laundering
Laws. The operations of the Company are and have been conducted at all times in compliance with applicable financial recordkeeping
and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, but
not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of 2001
and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the
Company, threatened.

 

(k) Absence of Litigation. There is
no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory
organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of the Company’s
officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

(l) No General Solicitation. Neither
the Company, nor any of its officers, managers, employees, agents or members has either directly or indirectly, including, through
a broker or finder (i) engaged in any general solicitation or (ii) published any advertisement in connection with the offer and
sale of the Subscribed Securities.

 

(m) Non-Public Information. The Company
represents and warrants that none of the information conveyed to the Purchaser in connection with the transactions contemplated
by this Agreement will constitute material non-public information of the Company upon the effectiveness of the Registration Statement.

 

(n) No Other Representations and Warranties;
Non-Reliance. Except for the specific representations and warranties contained in this Section 4 and in any certificate
or agreement delivered pursuant hereto, none of the Company Parties has made, makes or shall be deemed to make any other express
or implied representation or warranty with respect to the Company or the offering of Securities hereunder, and the Company Parties
disclaim any such representation or warranty. Except for the specific representations and warranties expressly made by the Purchaser
in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the Company Parties specifically
disclaim that they are relying upon any other representations or warranties that may have been made by the Purchaser Parties.

 

     

     

    

 

4. Additional Agreements and Acknowledgements of the Purchaser.

 

(a) Transfer Restrictions The Purchaser
agrees that it shall not Transfer (as defined below) (i) any Class B Shares until the earlier of (A) six months after the closing
of the Business Combination (the “Business Combination Closing”) and (B) the date following the Business Combination
Closing on which the Company completes a liquidation, merger, stock exchange or other similar transaction that results in all
of the Company’s stockholders having the right to exchange their Common Stock for cash, securities or other property (such
period, the “Lock-up Period”) or (ii) any Private Placement Units (or securities issuable upon exercise of
the Private Placement Warrants) until 30 days after the Business Combination Closing. Notwithstanding the foregoing, if subsequent
to a Business Combination, the closing price of the Class A Common Stock equals or exceeds $12.00 per share (as adjusted for share
splits, share dividends, reorganizations, recapitalizations and the like) for any twenty (20) trading days within any thirty (30)
trading day period commencing at least sixty (60) days after the Business Combination Closing, the Class B Shares shall be released
from the lockup referenced in this Section 4(a). Notwithstanding the first sentence hereinabove, transfers of the Securities
are permitted (i) to the Company’s officers or directors, any affiliates or family members of the Company’s officers
or directors, any affiliate or member of the sponsor or other initial stockholders of the Company, or any of such affiliate’s
or member’s affiliates, officers, directors and director or indirect equityholders, or any affiliate of the Purchaser; (ii)
in the case of an individual, by gift to a member of the individual’s immediate family, to a trust, the beneficiary of which
is a member of the individual’s immediate family or an affiliate of such person or to a charitable organization; (iii) in
the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (iv) in the case of an
individual, pursuant to a qualified domestic relations order; (v) in the case of an entity, as a distribution to its partners,
stockholders or members upon liquidation; (vi) by private sales or transfers made in connection with the consummation of a Business
Combination at prices no greater than the price at which the applicable Securities were originally purchased; (vii) in the event
of the Company’s liquidation, bankruptcy or dissolution prior to the completion of a Business Combination; (viii) by virtue
of the laws of Delaware or the Purchaser’s limited liability company agreement upon dissolution of the Purchaser; (ix) to
a nominee or custodian of a person or entity to whom a disposition or transfer would be permissible under clauses (i) through
(viii) above; and (x) pursuant to the provisions of Section 2 of this Agreement (each of the foregoing, a “Permitted
Transferee”); provided, however, that in the case of clauses (i) through (vii), and (ix), these Permitted Transferees
must enter into a written agreement agreeing to be bound by the terms of this Agreement, whereupon such Permitted Transferee will
be treated as a Purchaser for all purposes of this Agreement, with the same rights, benefits and obligations of the Purchaser
hereunder, including the provisions of Section 2 and these transfer restrictions. As used in this Agreement, “Transfer”
shall mean the (x) sale of, offer to sell, contract or agreement to sell, hypothecation, pledge, grant of any option to purchase
or otherwise dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position (within the meaning of Section 16 of the Securities Exchange
Act of 1934, as amended (the “Exchange Act”), and the rules and regulations of the SEC promulgated thereunder)
with respect to, any of the Securities; (y) entry into any swap or other arrangement that transfers to another, in whole or in
part, any of the economic consequences of ownership of any of the Securities, whether any such transaction is to be settled by
delivery of such Securities, in cash or otherwise, or (z) public announcement of any intention to effect any transaction specified
in clause (x) or (y). For the avoidance of doubt, the restrictions contained in this Section 4(a) shall apply only to Transfers
by the Purchaser of Securities acquired by the Purchaser pursuant to this Agreement, and nothing contained in this Section 4(a)
shall prohibit the Purchaser from Transferring any securities of the Company acquired in the open market, privately negotiated
transactions, or otherwise not pursuant to this Agreement.

 

(b) Trust Account.

 

(i) The Purchaser hereby acknowledges that it is aware
that the Company will establish the Trust Account for the benefit of its public stockholders upon the IPO Closing. The
Purchaser hereby agrees that, solely with respect to the Class B Shares and Class A Shares underlying the Private Placement
Units held by the Purchaser, it has no right, title, interest or claim of any kind in or to any monies held in the Trust
Account, as a result of any liquidation of the Company. The foregoing acknowledgement shall not affect any rights, including
redemption and liquidation rights, if any, the Purchaser may have in respect of any Public Shares held by it.

 

(ii) The Purchaser hereby agrees
that it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”) to, or
to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it
may have now or in the future, except for redemption, liquidation, and other rights, if any, the Purchaser may have in respect
of any Public Shares held by it. In the event the Purchaser has any Claim against the Company under this Agreement, the Purchaser
shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any
monies in the Trust Account, except for redemption, liquidation, and other rights, if any, the Purchaser may have in respect of
any Public Shares held by it.

 

5. General Provisions.

 

(a) Notices. All notices and other
communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier
of actual receipt, or (i) personal delivery to the party to be notified, (ii) when sent, if sent by electronic mail or facsimile
(if any) during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s
next Business Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested,
postage prepaid, or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying
next Business Day delivery, with written verification of receipt. All communications sent to the Company shall be sent to: Growth
Capital Acquisition Corp. c/o Maxim Group LLC, The Chrysler Building, 405 Lexington Ave, New York, NY 10174, Attention: George
Syllantavos, Email: gs@stellaracquisition.com, with a copy to Ellenoff Grossman & Schole LLP, 1345 Avenue of the Americas,
11th Floor, New York, NY 10105, Attention: Jeffrey Rubin, Email: jrubin@egsllp.com.

 

     

     

    

 

All communications to the Purchaser shall
be sent to the Purchaser’s address as set forth on the signature page hereto, or to such email address, facsimile number
(if any) or address as subsequently modified by written notice given in accordance with this Section 5(a).

 

(b) No Finder’s Fees. Each party
represents that it neither is nor will be obligated for any finder’s fee or commission in connection with this transaction.
The Purchaser agrees to indemnify and to hold harmless the Company from any liability for any commission or compensation in the
nature of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against
such liability or asserted liability) for which the Purchaser or any of its officers, employees or representatives are responsible.
The Company agrees to indemnify and hold harmless the Purchaser from any liability for any commission or compensation in the nature
of a finder’s or broker’s fee arising out of this transaction (and the costs and expenses of defending against such
liability or asserted liability) for which the Company or any of its officers, employees or representatives is responsible.

 

(c) Survival of Representations and Warranties.
All of the representations and warranties contained herein shall survive the consummation of the transactions contemplated by
this Agreement.

 

(d) Entire Agreement. This Agreement,
together with any other documents, instruments and writings that are delivered pursuant hereto or referenced herein, constitutes
the entire agreement and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings,
agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject
matter hereof or the transactions contemplated hereby.

 

(e) Successors. All of the terms,
agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to the benefit
of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies,
obligations or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f) Assignments. Except as otherwise
specifically provided herein, no party hereto may assign either this Agreement or any of its rights, interests, or obligations
hereunder without the prior written approval of the other party.

 

(g) Counterparts. This Agreement may
be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute one
and the same instrument.

 

(h) Headings. The section headings
contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation of
this Agreement.

 

(i) Governing Law. This Agreement,
the entire relationship of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute,
law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of the State of New York,
without giving effect to its choice of laws principles.

 

(j) Jurisdiction. The parties hereby
irrevocably and unconditionally (i) submit to the jurisdiction of the state courts of New York and the United States District
Court for the Southern District of New York for the purpose of any suit, action or other proceeding arising out of or based upon
this Agreement, (ii) agree not to commence any suit, action or other proceeding arising out of or based upon this Agreement except
in state courts of New York or the United States District Court for the Southern District of New York, and (iii) waive, and agree
not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not
subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or execution,
that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the

suit, action or proceeding is improper or that this Agreement
or the subject matter hereof may not be enforced in or by such court.

 

     

     

    

 

(k) WAIVER OF JURY TRIAL. THE PARTIES
HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION PURSUANT TO THIS AGREEMENT AND THE TRANSACTIONS
CONTEMPLATED HEREBY.

 

(l) Amendments. This Agreement may
not be amended, modified or waived as to any particular provision, except with the prior written consent of the Company and the
Purchaser.

 

(m) Severability. The provisions of
this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the validity or
enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any party hereto
or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with
its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator making such determination will have
the power to modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific
words or phrases, and in its reduced form, such provision will then be enforceable and will be enforced.

 

(n) Expenses. Each of the Company
and the Purchaser will bear its own costs and expenses incurred in connection with the preparation, execution and performance
of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives,
financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of its transfer agent, stamp
taxes and all other fees associated with the issuance of the Securities and the securities issuable upon conversion or exercise
of the Securities.

 

(o) Construction. The parties hereto
have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation
arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will
arise favoring or disfavoring any party hereto because of the authorship of any provision of this Agreement. Any reference to
any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules and regulations promulgated
thereunder, unless the context requires otherwise. The words “include,” “includes,” and “including”
will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be
construed to include any other gender, and words in the singular form will be construed to include the plural and vice versa,
unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
 “hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision
unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will
have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in
any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless
of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that
such party hereto is in breach of the first representation, warranty, or covenant.

 

(p) Waiver. No waiver by any party
hereto of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, may be deemed
to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any
way any rights arising because of any prior or subsequent occurrence.

 

(q) Specific Performance. Each party
hereto agrees that irreparable damage may occur in the event any provision of this Agreement was not performed by the other party
hereto in accordance with the terms hereof and that the such party shall be entitled to specific performance of the terms hereof,
in addition to any other remedy at law or equity.

 

[Signature page follows]

 

     

     

    

 

IN WITNESS WHEREOF, the undersigned have executed this
Agreement to be effective as of the date first set forth above.

 

COMPANY:

 

GROWTH CAPITAL ACQUISITION CORP.

 

 

By:        /s/ George Syllantavos                                     

Name:  George Syllantavos

Title:    co-CEO

 

[Signature Page to Subscription Agreement]

 

	 	PURCHASER:	 
	 	 	 	 
	 	Nautilus Carriers LLC	 
	 	 	 	 
	 	 	 	 
	 	By:	   /s/ Prouopios Tsirigakis	 
	 	Name: Prouopios Tsirigakis	 
	 	Title:   President	 
	 	 	 	 
	 	Purchaser’s Address for Notices:	 
	 	 	 	 
	 	 	 	 
	 	with copies to:	 

 

[Signature Page to Subscription Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]